[Beta-adrenergic agonists (adrenaline, dopamine, dobutamine, salbutamol), beta-blockers. Principles and regulations of use].
Colin
P
P
Département de pharmacologie (INSERM E00.01), faculté de médecine Paris Sud, 94276 Le Kremlin-Bicêtre.
Berdeaux
A
A
D000318:Adrenergic beta-Agonists / Q000494:pharmacology* / Q000627:therapeutic use*; D000420:Albuterol / Q000494:pharmacology / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy; D004280:Dobutamine / Q000494:pharmacology / Q000627:therapeutic use; D004298:Dopamine / Q000494:pharmacology / Q000627:therapeutic use; D004837:Epinephrine / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D051437:Renal Insufficiency / Q000188:drug therapy; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000502:physiology
D000318:Adrenergic beta-Agonists; D004280:Dobutamine; D000420:Albuterol; D004298:Dopamine; D004837:Epinephrine